Sarah Lynn Patterson

Sarah Patterson practices at UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health.

Sarah Patterson's NPI, 1346531175, was assigned on April 27, 2011. Sarah Patterson graduated from UCSF School of Medicine in 2011. Sarah Patterson holds California license A123829.

Sarah Patterson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights, at 505 Parnassus Ave, Box 0296, San Francisco, CA 94143 in San Francisco County. The practice phone is (415) 353-2733.

Sarah Patterson's primary practice is UCSF Helen Diller Medical Center at Parnassus Heights in San Francisco, California, part of University of California Health. The medical group on file is UCSF Pediatrics. Dmand AI also links Sarah Patterson to 3 more medical groups, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Sarah Patterson practices. Vendor and product names are available with a free account.

Rheumatology is Sarah Patterson's primary specialty in the NPI Registry, under taxonomy code 207RR0500X. Sarah Patterson is licensed in California.

Dmand AI lists chronic lung disease, immune deficiency disease, lupus, osteoporosis, psoriasis and rheumatoid arthritis among the conditions Sarah Patterson treats.

CMS data shows 70 Medicare services from Sarah Patterson across 2 procedure codes in 2024, for 37 Medicare patients. Medicare paid $5,365 for them. Every service was in a facility, such as a hospital, rather than an office.

CMS counts 37 Medicare patients who saw Sarah Patterson in 2024. The largest group is 65 to 74, with 14 patients. 70% of them have arthritis, and 62% have high blood pressure. 46% are also on Medicaid. Their average risk score is 2.48, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Sarah Patterson's median patient age at 51, with 76% women.

In 2024, Sarah Patterson wrote 171 Medicare Part D claims for 16 patients. 75% of them were for generic drugs. CMS names the drug for 93 of them, across 5 drugs with 11 or more claims each, at $258,973 in total drug cost. In 2023, CMS named 68 claims across 4 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 100 out of 100 for Sarah Patterson for performance year 2024, reported as part of a group. Sarah Patterson accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Sarah Patterson as offering telehealth.

Dmand AI links 15 papers to Sarah Patterson, published from 2017 to 2025. 2023 was the busiest year, with 2. The most frequent topics are Lupus Erythematosus, Systemic, Arthritis, Rheumatoid and Cytokines. Sarah Patterson has published most often in Arthritis Care Res (Hoboken). Sarah Patterson's most frequent co-authors are Jinoos Yazdany, MD, Charles Regis Langelier, MD, PhD and Gabriela Schmajuk, MD.

Dmand AI links Sarah Patterson to 1 clinical trial. Conditions studied include Arthritis, Rheumatoid and Rheumatic Diseases.

CMS Open Payments shows 1 general payment to Sarah Patterson from 1 drug or device company in 2025. Education make up the largest share, 100% of the total. Janssen Pharmaceuticals, Inc paid the most, $100.

Sarah Patterson graduated from UCSF School of Medicine in 2011.

Sarah Patterson is in network with 9 carriers, including Aetna, Blue Cross Blue Shield of Michigan and United Healthcare. Medicare plans come from the most carriers, 7. Check the plan with the practice before a visit.